Posted by AGORACOM
at 8:31 PM on Monday, September 21st, 2020
Sweet Earth’s award-winning canine products will be sold under Thoughtful Brands’ Nature’s Exclusive brand, leveraging the Company’s eCommerce capabilities
VANCOUVER, BC / ACCESSWIRE / September 21, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), a global natural health products and eCommerce technology company, is excited to announce that the company has signed a Supply Agreement with Sweet Earth Holdings Corp. (CSE:SE) (FSE:1KZ1) (“Sweet Earth“), a vertically-integrated hemp company cultivating high-quality CBD products grown in Applegate Valley, Oregon. Sweet Earth is now officially the exclusive CBD dog treat provider to Thoughtful Brands’ direct to consumer brand, Nature’s Exclusive.
The agreement enables the Sweet Earth-produced CBD canine products to utilize Thoughtful Brands’ newly formed Ecommerce Tech LLC, a subsidiary operating a powerful ecommerce software platform designed to maximize customer acquisition and customer service.
The market for pet CBD products is booming: research sponsored earlier this year by RestoraPet and conducted by BDS Analytics and Arcview Market Research projects the pet CBD market to grow five percent faster than the overall CBD market over the next four years, from $64 million in 2018 to $810 million in 2024.
Sweet Earth canine products that will be sold under the Nature’s Exclusive brand include the popular Beef and Cheddar Potato CBD Dog Treats. Sweet Earth’s offerings are Leaping Bunny-certified, the gold-standard in cruelty-free certification for consumer goods signifying no new animal tests were conducted during product development.
“We are thrilled to be working with Sweet Earth, a renowned company whose sophisticated hemp-CBD offerings have long been celebrated,” said Thoughtful Brands CEO Ryan Dean Hoggan. “We are eager to propel the success of their CBD canine products by utilizing our global eCommerce platform and enhanced technology capabilities. We look forward to adding the brand to our portfolio and are hopeful for additional collaborations in the future.”
Building off the success of Nature’s Exclusive and the supply agreement with Sweet Earth, Thoughtful Brands is continuing to expand its portfolio in the nutraceutical and hemp-based CBD product space through the August 2020 acquisition of Golden Path LLC and Wild Mariposa LLC, two direct-to-consumer eCommerce brands offering natural health products throughout the U.S.
Sweet Earth’s CEO, Peter Espig, commented, “We are very excited to work closely with Thoughtful Brands, a company that we feel maintains the hemp industry’s premier brands. The company is well managed, maintains a powerful global platform and enhanced technological capabilities, and constantly researches for new methods of increasing customer service. We look forward to adding our products to Thoughtful Brand’s rapidly growing eCommerce platform, and are hopeful for future collaborations.”
In addition to the above, the Company announces the resignation of Szascha Lim as Chief Financial Officer. The role will be fulfilled once the appropriate person is found.
About Thoughtful Brands Inc.
Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.
ON BEHALF OF THE BOARD OF DIRECTORS THOUGHTFUL BRANDS INC.
Ryan Hoggan Chief Executive Officer
For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected]
Posted by AGORACOM
at 7:02 PM on Monday, September 21st, 2020
VANCOUVER, BC, Sept. 21, 2020 /CNW/ – Tajiri Resources Corp. (the “Company”) (TSXV: TAJ) is pleased to announce that reverse circulation drilling commenced September 18, 2020 at the advanced Morley Prospect situated on the Company’s wholly owned ~1,100km2 Reo Project, located 150 km west northwest of the capital of Burkina Faso, Ouagdougou.
At Morley, where historic drilling, conducted between 2008 and 2012, intersected shallow high-grade gold intersections such as:
32m @ 17.5g/t from 2m,
6m @ 38.9g/t from 8m,
2m @ 18.0g/t from 17m,
10m @ 9.6g/t from 74m,
1m @ 75.5.5g/t from 33m,
6m @ 4.1g/t from 60m,
8m @ 9.4g/t from 16m,
10m @ 7.6g/t from 16m;
Gold mineralisation is hosted by low sulphidation quartz veins in granodiorite situated ~400m from a regional scale contact between the granodiorite and greenstones. Modelling of mineralisation at Morley by Tajiri suggests that the orientation of mineralisation is parallel to a set of late tensional structures that are disposed at an high angle to regional belt strike and such structures elsewhere in Burkina host significant high grade gold mineralisation e.g. Rox Gold’s Yaramoko Mine and West African Resources’ M1 South Deposit.
The purposes of the current 3,600m drill program are several:
to test strike and dip continuity of mineralisation over a 400m strike x 130m down dip portion of mineralisation;
to test the possibility for stacked lodes within a 400m (l) x 250m (w) x 130m (d) volume mostly above the main interpreted lode which strikes NW and dips 35-60˚ to the NE;
to obtain samples for preliminary cyanide bottle roll tests;
to delineate any higher grade shoots and their orientation within the broader mineralised envelope;
to lay a solid foundation for step out drilling, along strike, across strike and down dip; and
to advance the Morley prospect toward an initial inferred resource estimate.
Tajiri expects to release first results from its maiden drill program at Morley within the next 3 to 4 weeks and expects to complete drilling within 5 to 6 weeks. After which the contracted rig will move 20km south to the K4-K5 prospect where a further 4,000m of RC drilling is planned.
The Company also wishes to clarify finder fee amounts paid on the closing of a non-brokered private placement, as reported in news released August 19th, 2020 and updated September 3rd, 2020; being that total finders warrants issued in relation to the offering were 1,116,933 while cash consideration was $191,620. All other details remain the same.
Posted by AGORACOM
at 10:04 AM on Monday, September 21st, 2020
Toronto, Ontario–(Newsfile Corp. – September 21, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has granted a prominent Canadian production company and film crew exclusive access to provide video coverage of the activities of the Company and its Chief Executive Officer, Todd Shapiro, within the Netherlands, leading up to the Company’s previously announced iMicrodose product launch party (the “iMicrodoseLaunch Party“), scheduled on September 25, 2020, in Amsterdam, the Netherlands. Filming commenced on September 20, 2020 in Horst, the Netherlands (the location of the Company’s production and distribution facility) and will continue through to the iMicrodose Launch Party, covering, among other things, the iMicrodose brand, and the production and distribution facility.
“I’m so grateful for this production company reaching out and offering to document our journey. There’s a ton of hard work that is going on behind the scenes and if all goes according to plan – this will be another piece of earned Media, which hasn’t cost Red Light Holland a dime, to potentially highlight our Company, our tireless efforts and our iMicrodose brand to a much bigger widespread audience,” said Chief Executive Officer and Director of the Company, Todd Shapiro. “Out of respect to the production company’s intellectual property rights, which play a huge role in stimulating innovation and creativity – in this case focusing on Red Light Holland’s early magic truffles production facility, our iMicrodose product launch in the Netherlands, and our expected iMicrodose Launch Party – we’ve mutually agreed to hold off on providing more information for now. However, we look forward to sharing more details in early 2021 about this great exposure opportunity… Now let’s just hope my mug doesn’t get left on the cutting room floor!”
About Red Light Holland Corp.
The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM-JC
at 9:57 AM on Monday, September 21st, 2020
SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.
Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17
Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
The company offered 0.8 million more ADSs than anticipated
At pricing, the company raised 27% more in proceeds than expected
Contributor: Renaissance Capital
COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.
COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.
The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Posted by AGORACOM-JC
at 9:32 AM on Monday, September 21st, 2020
Company has launched its new domain www.PlantX.ca to better serve the Canadian market
New .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform
VANCOUVER, BC, Sept. 21, 2020 – Vegaste Technologies Corp. (the ” Company ” or ” Vegaste “) (CSE: VEGA ), is pleased to announce that the Company has launched its new domain www.PlantX.ca to better serve the Canadian market.
The new .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform.
The new domain www.PlantX.ca will feature a growing list of partnerships with Canadian companies including Vita Life Fresh Market and UpMeals to offer plant-based vitamins, supplements, groceries, PlantX-branded water and plant-based meals made by LA-based chef Gregg Drusinsky . In addition to its e-commerce functionality, the site will offer Canadian consumers weekly updated plant-based recipes, restaurant resources and connects like-minded users in a community forum.
“Having a “.ca” domain is very exciting for us as a Canadian-based company,” said Sean Dollinger , PlantX founder “We plan to use this as an example of what we can do around the world as we expand, continue making new partnerships, and offer the best products and experience in every market.”
“At PlantX we’ve built our online platform with a different set of inventory, shipping logistics, payment processors, and other logistics separated by region,” says Alexandra Hoffman , PlantX Chief Marketing Officer. “Dividing the company traffic among different domains makes the company’s regional logistics systems better. I work very close with our development team, and it’s so exciting to see how quickly we can deploy sites for new locations.”
Since its inception in October, 2019, the Company’s PlantX platform has quickly emerged as an industry leader. As the fledgling plant-based sector continues its explosive growth, the Company will be at the forefront by continually evolving and delivering new ways to expand PlantX. With its forward-looking, cutting edge approach, the Company will continue to secure significant partnerships across North America while exploring innovative ways to expand both its e-commerce capabilities and digital resources to help educate, inspire, and uplift consumers.
About Vegaste
As the digital face of the plant-based community, Vegaste’s PlantX platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company will offer customers across North America more than 10,000 plant-based products by the end of September. In addition to offering meal and indoor plant deliveries, Vegaste currently has plans underway to expand its product lines to include cosmetics, vitamins, clothing, and its own water brand — but the business is not limited to an e-commerce platform. Vegaste uses its digital platform to build a community of like-minded consumers and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. Vegaste eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.
The Company’s lynchpin www.PlantX.com is the digital face of everything plant-based and fueled by the power of education and accessibility. For those who don’t have the time to cook their own healthy plant-based meals, Vegaste offers a wide array of pre-made meals curated by Executive Chefs and nutritionists. For those looking to learn how to cook their own plant-based meals, Vegaste offers regularly updated weekly recipes. Unlike other plant-based e-commerce companies, Vegaste has a large selection of indoor plants for sale. The site educates consumers on the benefits of a plant-based diet with a specialized blog, connects like-minded individuals with its forum, and provides resources for the best plant-based restaurants, pop-up retailers and products across Canada and the USA .
Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the business and strategic plans of the Company.
By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to secure additional commercial partnerships across North America , the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:27 AM on Monday, September 21st, 2020
Avicanna Rapid Act Spray
RHO Phyto™ Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers™ portal.
The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side RHO Phyto’s Micro Drop Oil formulations.
TORONTO , Sept. 21, 2020 – Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (” Shoppers “) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network.
Avicanna’s RHO Phyto product line is now commercially available after years of research and development through collaborations with world class academic and clinical organizations. The development of RHO Phyto products has focused on the key properties in drug development that health care providers seek when recommending a medical product to their patients such as formulation stability for consistent dosing, enhanced absorption and a range of onset times.
The Rapid Act Spray is a sublingual spray and is among the second set of Avicanna’s RHO Phyto products available for purchase through Shoppers. The sublingual sprays bypass first-pass metabolism and are quickly absorbed in the mucosal lining under the tongue. The RHO Phyto Rapid Act Spray provides an alternative delivery form to the RHO Phyto Micro Drops (also available for sale through Shoppers) which are absorbed through the oral route. The RHO Phyto Rapid Act Sprays have been formulated with specific ingredients that enhance absorption and the onset time of cannabinoids across the mucous membrane beneath the tongue. The lemon-mint flavoured sprays will be available in 10:20 CBD and 2:40 (w/w) THC to CBD ratios.
Dr. Justin Grant , Avicanna’s Executive Vice President of Scientific Affairs, commented, “The RHO Phyto Rapid Act Sprays are designed for faster onset and can be used in acute conditions where patients seek faster relief. The sublingual sprays can also be used to supplement slower and longer acting products, such as the RHO Phyto Micro Drop, when occasional higher doses may be required. Sublingual administration provides an alternative to the potentially harmful effects of consuming inhalation products.”
In August 2020 , Avicanna launched its blood orange flavoured RHO Phyto Micro Drop 2:50 CBD and Micro Drop 5:20 CBD. In the coming months, Avicanna will be launching its much-anticipated RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules. To ensure batch-to-batch consistency and high-quality products, these formulations are manufactured at MediPharm Labs Inc, a Good Manufacturing Practices (” GMP “) certified facility. In addition to strict GMP manufacturing, all RHO Phyto products undergo GMP-level analytical testing by Sigma Analytical Services Inc. and use blockchain technology developed by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.
Detailed guidelines outlining dosing and titration for Health Care Practitioners (” HCPs “) and patients is available on the RHO Phyto website at www.rhophyto.com . In addition, the Avicanna Academy includes additional product information for patients, frequently asked questions, and a recording of Avicanna’s 3rd annual symposium which was hosted virtually in partnership with Shoppers on July 21, 2020. For more information visit https://www.avicanna.com/the-avicanna-academy/ .
The Company has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly known as My Cannabis), which specializes in assisting patients to gain access to medical cannabis and cannabinoid-based products for medical use. My Cannabis Clinic is devoted to providing HCPs and patients with the support and education needed for medical cannabis use. My Cannabis Clinic believes in providing quality care to patients and providing education on the considerations and potential benefits that cannabis has to offer for medical use. Information about My Cannabis Clinic can be found at https://mycannabisclinic.org/ .
About Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the RHO Phyto Rapid Act Sprays to be used in acute conditions where patients seek faster relief, the ability of the RHO Phyto Rapid Act Sprays to be used to supplement slower and longer acting products, the ability of the Company launching the RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules , the ability of My Cannabis Clinic to provide HCPs and patients with the support and education needed for medical cannabis use, and that there is a benefit to using cannabis for medical purposes. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 9:19 AM on Monday, September 21st, 2020
Announced that it has received a third Purchase Order for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020
This production is scheduled to run for three (3) months, totalling $630,000.
Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits
Toronto, Ontario–(September 21, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has received a third Purchase Order (“P.O.”) for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
The miniseries is produced by Nickelodeon Productions and distributed by MTV Networks in the United States and YTV in Canada, a Corus Entertainment company. Nickelodeon, now in its 41st year, is the number one entertainment brand for kids. Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc.
The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020. This production is scheduled to run for three (3) months, totalling $630,000. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.
As previously stated, Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.
Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide, including in Vancouver, which represents 37% of Canadian Productions. The surrounding areas of Vancouver had 46 productions filming, which does not include the TV commercial market. Each of the shows potentially had a minimum of 100 people in their film crew.1
The next largest film and television market is Ontario, which represents 34% of Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 Billion in production volume.
Additionally, with Canada having far fewer cases of COVID-19 than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming and an advocate for the film industry, with our testing kits, collection services and labs already set up.
“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new film business for COVID-19 screening business,” said Marshall Gunter, CEO of the Company.
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:16 AM on Monday, September 21st, 2020
Announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately
Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services
MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.
“Naman’s extensive background in healthcare and medical devices, along with his deep relationships will allow us to accelerate business development opportunities in the region,” said Mike Druhan, President of Dermatological Products & Services. “Chantal is an internationally recognized and respected leader in the dermatology and aesthetics spaces, bringing credibility to our offerings and putting an impressive opinion leader network at our disposal.”
Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.
“Helping patients access an e-consult on suspicious lesions or moles quickly and easily means better treatment and better outcomes,” noted Mr. Demaghlatrous. “There is already significant interest and traction across the region and I am expecting substantial growth over the next six to nine months.”
Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.
“I have been using this device in my clinic for several years and have caught multiple melanomas,” said Ms. Ward. “The device is easy to use and the ability to have a dermatologist provide a remote e-consult, within 72 hours, is critical. Early detection is the key to a successful patient outcome.”
“MedX is in full commercialization mode and Naman and Chantal are welcomed additions to our team. Recently, Damon Goodwin and Nick Hoffman have been announced to our senior management team and we are already feeling their impact. It is a satisfying to know that MedX can attract such seasoned professionals and I strongly believe that is because of the strength of our technology offering and the culture we have built,” further commented Mr. Druhan.
Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.
Posted by AGORACOM-JC
at 9:11 AM on Monday, September 21st, 2020
Company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature
Loop announced an exciting successful launch with Telus, Canada’s leading telecom company
Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals
The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America
company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development application
VANCOUVER, BC, Sept. 21, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, automated marketing, and contact tracing to the brick and mortar space, is pleased to provide shareholders with the following corporate update reviewing recent significant business wins and near term expectations. The company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature.
BUSINESS DEVELOPMENT OPPORTUNITIES EXPANDING WITH EACH SUCCESSIVE WIN
Loop CEO Rob Anson stated “We have long known that our artificial intelligence driven technology stack could have a major impact on the real-world operations of enterprise-level customers, so it has been an incredible experience for Loop and its shareholders to begin seeing the third-party validation as we secure deals with great partners such as Telus, University of Houston and others. My message to shareholders is this is only the beginning, with Loop receiving significant inquiries, conducting online demonstrations and entering contract discussions on a daily basis. Moreover, we remain laser focused on maximizing our potential through Tier-1 channel resellers to help us grow even faster. As such, I can say with great confidence that Loop is extremely well-positioned to anticipate a very strong and successful run for the remainder of 2020.
TELUS PARTNERSHIP IS INDICATIVE OF A GLOBAL DISTRIBUTION STRATEGY WITH NATIONAL TELECOM PROVIDERS
On September 17th, Loop announced an exciting successful launch with Telus, Canada’s leading telecom company. This pilot program of our real-time, artificial intelligence-driven marketing platform launched in August and, upon successful completion, sees expansion into Telus 550+ corporate locations, as well as, their 2,000+ B2B reseller channel. This partnership is part of Loop’s global distribution strategy, in which the Company is already engaged in discussions with several similar telecom providers in the US, Australia, and other regions.
CONTACT TRACING ACCELERATES WITH INQUIRIES FROM GOVERNMENTS FOLLOWING PARTNERSHIP WITH NCAA DIV 1 UNIVERSITY OF HOUSTON
Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals. The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America. Areas of interest have come from, but not limited to, Provincial and Federal Government talks. Now that schools and sports teams are starting back up, contact tracing needs have never been as important. Securing University of Houston was a huge milestone and has now sparked interest throughout many other sports teams and schools across the US looking to restart and have a safe return of fans to their sporting facilities. Final negotiations are underway and the Company hopes to announce the next roll out in the near future.
LOOP RECEIVES $412,000 FROM FEDERAL GOVERNMENT SR&D RESEARCH AND DEVELOPMENT PROGRAM
The company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development (“SR&ED”) application. In order to qualify for this program, Loop had to demonstrate it “generated information that advances the understanding of scientific relations or technologies or advances a certain technology or overcomes a technological uncertainty.”
This additional injection of funds further strengthens the company’s strong cash position, which positions the Company well for future M&A opportunities.
LOOP OTCQB APPLICATION IN FINAL STAGES IN RESPONSE TO US INVESTOR DEMAN
Over the past months, the Company has received increasing inquiries from US-based investors who could not easily acquire shares in Loop. As a result, the company submitted applications to the necessary regulatory bodies and is hopeful for final approval as early as this week, making Loop shares available for trading on the OTCQB with full DTC eligibility.
LOOP PARTNERSHIP WITH LEADING POS VENDOR (VEND) YIELDS IMMEDIATE RESULTS WITH NEW CUSTOMERS
Another major milestone was the partnership with Vend, a global point of sale supplier with over 25,000 locations in over 142 companies. Upon successful completion of the integration with Vend, Loop has already signed several Vend retailers including Your CBD Store, the largest CBD brick and mortar retailer in the United States with over 650 locations.
The Company is now in discussions on a distribution strategy with Vend’s leadership team to become a global reseller of the Loop products which will help accelerate Loop’s potential adoption throughout Vends global network of retailers.
As next steps in leveraging the success with Vend, the Company has also begun an integration roll out with one of the largest e-commerce platforms. Point of sale partners continues to be a large focus as they are the Company’s quickest path to scale while allowing the Company to remain lean and agile.
About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
SOURCE LOOP Insights Inc.
For further information: Loop Insights Inc., Rob Anson, CEO, T: +1 877-754-5336 Ext. 4, E: [email protected], LOOP Website: www.loopinsights.ai, Facebook: @LoopInsights, Twitter: @LoopInsights, LinkedIn: @LoopInsights
Posted by AGORACOM
at 8:24 AM on Monday, September 21st, 2020
TORONTO, ON / ACCESSWIRE / September 21, 2020 / Tartisan Nickel Corp. (CSE:TN)(OTC PINK:TTSRF)(FSE:A2D) (“Tartisan”, or the “Company”) is pleased to announce that the Company has appointed Thomas Larsen, Dean MacEachern and Ronald Wortel as advisors to the Company. The Board of Directors welcomes them on behalf of all shareholders.
THOMAS LARSEN, CEO ELORO RESOURCES LTD.
Thomas Larsen is an executive in the resources sector with over 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of $150 million. Mr. Larsen is currently the Chief Executive Officer of Eloro Resources Ltd. and Cartier Iron Corporation. Additionally, Mr. Larsen previously held the position of President and Chief Executive Officer of Champion Iron Limited.
DEAN MACEACHERN, B.SC. (HONS), P.GEO.
Mr. MacEachern has thirty years of exploration experience, seventeen of which were with Falconbridge Limited (now Glencore), where he was involved with significant nickel, copper and zinc discoveries in the Sudbury and Timmins mining camps. He coordinated numerous base and precious metals exploration programs at several of the world’s major operating nickel copper zinc and PGM mining camps, including the Sudbury, Thompson and Abitibi Nickel Camps, the Kidd Creek VMS Camp in Canada and, the Bushveld PGM Camp in South Africa. He has been involved in developing projects with junior exploration companies in Canada, South America, and Europe for base and precious metal. Mr. MacEachern was the former President & CEO of Canadian Arrow Mines Limited.
RONALD WORTEL, B.A.SC. P.ENG., MBA
Mr. Wortel is a finance executive with over 20 years of experience in resource project analysis, transaction due diligence and financing. Starting in 1997, Mr. Wortel provided equity research coverage on the mining equity sector for sell side investment banks: National Bank, Dundee Capital and Northern Securities. Initially he covered the major gold companies and transitioned to the junior resource sector with an emphasis on near term production stories. In 2006, he joined Pathway Asset Management, a resource fund providing flow through funding to exploration companies. Here Mr. Wortel reviewed hundreds of gold and other resource projects as the fund placed over $1 billion into the sector.
CEO Mr. Mark Appleby said, “I am delighted to welcome these three gentlemen with their combined 90 years of experience and expertise in various disciplines. Their counsel should prove to be a valuable asset to the Company”.
About Tartisan Nickel Corp.
Tartisan Nickel Corp. is a Canadian based mineral exploration and development company which owns; the Kenbridge Nickel Project in northwestern Ontario, the Sill Lake Silver Property in Sault St. Marie, Ontario as well as the Don Pancho Manganese-Zinc-Lead-Silver Project in Peru. The Company has an equity stake in; Eloro Resources Limited, Class 1 Nickel & Technologies Limited and Peruvian Metals Corp.
Tartisan Nickel Corp. common shares are listed on the Canadian Securities Exchange (CSE:TN)(OTC PINK:TTSRF)(FSE:A2D). Currently, there are 101,603,550 shares outstanding (fully-diluted 107,203,550).
For further information, please contact Mr. Mark Appleby, President & CEO and a Director of Tartisan Nickel Corp. at 416-804-0280 ([email protected]). Additional information about Tartisan Nickel Corp. can be found at the Company’s website at www.tartisannickel.com or on SEDAR at www.sedar.com.
